Aspiration pneumonia: prevention and clinical management

Internal Medicine · Pulmonology · Infectious Disease

Aspiration pneumonia (AP) is an important cause of lower respiratory tract infection, particularly among older adults, hospitalised patients and individuals with neurological or swallowing disorders. It develops following the entry of colonised oropharyngeal or gastric contents into the lower respiratory tract, resulting in pulmonary infection and inflammation. Its occurrence is frequently associated with frailty, impaired swallowing mechanisms, reduced consciousness and compromised airway protective reflexes. Aspiration pneumonia may also complicate hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP), contributing to increased morbidity, prolonged hospitalisation and mortality.[1]The incidence of AP is expected to increase with population ageing and the growing prevalence of chronic neurological and respiratory disorders. It has been estimated to account for approximately 5%-24% of community-acquired pneumonia (CAP) admissions among older adults. Early recognition, identification of predisposing factors, appropriate antimicrobial treatment and preventive interventions are therefore essential to reduce disease burden and recurrence.Epidemiology and pathophysiologyAspiration pneumonia develops when microorganisms-containing secretions or gastric contents enter the lower respiratory tract and overcome pulmonary defence mechanisms. The composition of the lung microbiome, which shares similarities with oropharyngeal microbial communities, may influence infection development. Poor oral hygiene and periodontal disease can facilitate the colonisation of oral secretions by potentially pathogenic organisms, increasing the microbial burden of aspirated materialCommonly implicated pathogens include Staphylococcus aureus, Streptococcus pneumoniae, Klebsiella species and Escherichia coli. However, the microbial profile may vary according to the setting of acquisition, underlying comorbidities and previous antimicrobial exposureRisk factors for aspiration pneumoniaAspiration pneumonia is associated with conditions that interfere with swallowing, consciousness, gastric emptying or airway protective mechanisms. The major predisposing factors are summarised below: Risk categoryImportant contributing factorsImpaired swallowingOropharyngeal dysphagia, stroke, dementia, COPD and neurological disordersImpaired consciousnessHead injury, seizures, brain lesions, anaesthesia, alcohol, sedatives and certain medicationsIncreased aspiration of gastric contentsGastro-oesophageal reflux and enteral tube feedingImpaired cough reflexStroke, dementia, reduced consciousness and medication-related suppressionPoor oral healthPoor dentition, periodontal disease and increased oral colonisation by pathogenic bacteriaHealthcare-related factorsMechanical ventilation, prolonged hospitalisation and frailtyOlder adults are particularly vulnerable because age-related changes in swallowing coordination, cough effectiveness and immune function may increase the likelihood of aspiration and subsequent infection. Silent aspiration, in which material enters the airway without an obvious cough response, may further delay recognition.Clinical diagnosis and imagingThe diagnosis of aspiration pneumonia is primarily established through clinical assessment, aspiration history and radiological findings. However, universally accepted diagnostic criteria are lacking, and differentiation from other forms of pneumonia and aspiration pneumonitis may be challenging. Clinical manifestations commonly include cough, fever, breathlessness, increased sputum production and hypoxaemia, although presentations may be atypical in older or debilitated individualsChest radiography and computed tomography (CT) are important imaging modalities for identifying pulmonary infiltrates. Infiltrates involving dependent lung segments, particularly the right lower lobe, may increase the likelihood of aspiration pneumonia. However, a normal chest radiograph does not exclude the diagnosisLung ultrasonography may also be considered as a complementary diagnostic approach, particularly in bedridden or frail patients. Although inflammatory markers may support the assessment of infection severity, no specific biomarker has been established to confirm aspiration pneumonia. Bronchoscopy with bronchoalveolar lavage (BAL) may be considered in selected patients with severe disease or suspected resistant pathogens to facilitate microbiological assessmentAntimicrobial therapy and clinical managementAntimicrobial treatment is guided by the site of acquisition, clinical severity, radiographic findings, previous antimicrobial exposure and the risk of multidrug-resistant (MDR) organisms. Community-acquired and hospital-acquired aspiration pneumonia should be managed according to their respective local treatment protocols and susceptibility patternsFor community-acquired cases, Ampicillin-Sulbactam or Amoxicillin-Clavulanate may be considered, with alternative regimens selected according to disease severity, allergies and local resistance patterns. Ceftriaxone or respiratory fluoroquinolones may be appropriate in selected circumstances. In hospital-acquired cases, Piperacillin-Tazobactam, Cefepime or carbapenems may be considered when resistant gram-negative organisms are suspected. Additional coverage for resistant gram-positive organisms may be required according to individual risk factors and local guidelinesImportantly, routine additional anaerobic coverage is not recommended for every case of aspiration pneumonia. It is generally reserved for suspected lung abscess, empyema or necrotising infectionThe management approach should also account for the possibility of aspiration pneumonitis, which results from chemical injury following aspiration of gastric contents rather than an established bacterial infection. Antibiotics are not routinely indicated for uncomplicated aspiration pneumonitis. Patients with mild presentations and no convincing evidence of infection may be monitored, with antimicrobial treatment initiated if bacterial pneumonia subsequently develops.Key treatment considerations are summarised below: Clinical presentationManagement considerationsCommunity-acquired AP without MDR riskAmpicillin-Sulbactam or Amoxicillin-Clavulanate; alternatives based on clinical circumstancesHospital-acquired AP without MDR riskEmpirical treatment guided by local HAP protocols and antibiogramsSuspected MDR infectionBroader coverage, such as Piperacillin-Tazobactam, Cefepime or Meropenem, according to risk factorsSevere disease or septic shockHospital-based management, respiratory and haemodynamic support, appropriate empirical antibiotics and microbiological evaluationAspiration event with clear chest radiograph and mild symptomsClinical observation and reassessment rather than automatic antibiotic administrationAntimicrobial therapy should be reassessed within 48-72 hours using clinical response, microbiological findings and radiological progression. Treatment should subsequently be narrowed according to culture results, and the shortest appropriate duration should be selected based on clinical stability and complications.Prevention of aspiration pneumoniaPrevention is particularly important in older adults, patients with neurological disorders and individuals requiring prolonged hospitalisation. Interventions should primarily target swallowing dysfunction, oral microbial burden and impaired airway protection.Swallowing assessment: Patients with suspected dysphagia should undergo appropriate clinical swallowing evaluation. Speech and language therapy assessment and instrumental investigations, when indicated, may help identify aspiration riskOral hygiene: Regular toothbrushing, denture cleaning and professional oral care may reduce pathogenic bacterial colonisation and the microbial burden of aspirated secretionsFeeding precautions: Patients should be positioned upright during oral feeding and maintained in an appropriate position afterwards. Feeding should be supervised when swallowing difficulties are presentNutritional management: Appropriate food consistency and fluid modification should be guided by swallowing assessment. Enteral feeding should be individualised, as feeding tubes do not completely prevent aspirationMedication review: Sedatives and other medications that impair consciousness or suppress protective reflexes should be reviewed where clinically appropriateRespiratory care: Early mobilisation, effective secretion clearance and appropriate management of underlying respiratory disorders should be encouragedHospital infection prevention: Appropriate ventilator-care protocols, head-of-bed elevation when indicated and regular oral care should be implemented in critically ill patientsConclusionAspiration pneumonia represents a significant clinical challenge, particularly among frail older adults and hospitalised patients with swallowing dysfunction or neurological comorbidities. Early diagnosis, risk-based antimicrobial selection and multidisciplinary supportive care are essential for improving outcomes. Preventive strategies focusing on swallowing assessment, oral hygiene, safe feeding practices and aspiration-risk reduction remain central to minimising recurrence and associated complications.[2]Reference(s):1. Almirall J, Boixeda R, de la Torre MC, Torres A. Epidemiology and Pathogenesis of Aspiration Pneumonia. Semin Respir Crit Care Med. 2024;45(6):621-625. doi:10.1055/s-0044-1793907. https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0044-17939072. Niederman MS, Cilloniz C. Aspiration pneumonia. Rev Esp Quimioter. 2022;35 Suppl 1(Suppl 1):73-77. doi:10.37201/req/s01.17.2022. https://pmc.ncbi.nlm.nih.gov/articles/PMC9106188/#S4